Skip to main content

Peer Review reports

From: Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?

Original Submission
22 Sep 2018 Submitted Original manuscript
23 Nov 2018 Author responded Author comments - Ursula Vogl
26 Oct 2018 Reviewed Reviewer Report - Ana-Maria Florea
26 Oct 2018 Reviewed Reviewer Report - Mohamed Ebrahim
Resubmission - Version 2
23 Nov 2018 Submitted Manuscript version 2
19 Dec 2018 Author responded Author comments - Ursula Vogl
18 Dec 2018 Reviewed Reviewer Report - Ana-Maria Florea
Resubmission - Version 3
19 Dec 2018 Submitted Manuscript version 3
Publishing
21 Dec 2018 Editorially accepted
8 Jan 2019 Article published 10.1186/s12885-018-5240-6

You can find further information about peer review here.

Back to article page